Lancet Oncology

Published by: Elsevier Science, Inc.  

People

  1. Schoder
    Schoder
  2. Bodei
    Bodei
  3. Hricak
    Hricak
  4. Moskowitz
    Moskowitz
  5. Pandit-Taskar
    Pandit-Taskar
  6. Carrasquillo
    Carrasquillo
  7. Cheung
    Cheung
  8. Donzelli
    Donzelli
  9. Dunkel
    Dunkel
  10. Gonen
    Gonen

Groups

  1. Molecular Imaging and Therapy Service (10)
  2. Radiology, Department of (9)
  3. GSK Faculty (4)
  4. Molecular Pharmacology and Chemistry Program Faculty (4)
  5. Sloan Kettering Institute Faculty (4)
  6. Sloan Kettering Institute Postdocs (4)
  7. Center for Pancreatic Cancer Research (3)
  8. Department of Medicine (3)
  9. Advanced Practice Providers (2)
  10. Center for Hematologic Malignancies (2)
Search Within
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (8)
  2. Review (2)
Groups
  1. Molecular Imaging and Therapy Service (10)
  2. Radiology, Department of (9)
  3. GSK Faculty (4)
  4. Molecular Pharmacology and Chemistry Program Faculty (4)
  5. Sloan Kettering Institute Faculty (4)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Heiko Schoder (4)
  2. Hebert Vargas Alvarez (3)
  3. Alison Moskowitz (2)
  4. Craig Moskowitz (2)
  5. Hedvig Hricak (2)
  6. Lisa Bodei (2)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (3)
  4. 2018 (2)
  5. 2015 (2)
  6. 2007 (1)
Publishers
  1. Elsevier Science, Inc. (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop
    Review

    Shankar, L. K.; Schöder, H.; Sharon, E.; Wolchok, J.; Knopp, M. V.; Wahl, R. L.; Ellingson, B. M.; Hall, N. C.; Yaffe, M. J.; Towbin, A. J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • (177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): Final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
    Journal Article

    Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    Review

    Bodei, L.; Schöder, H.; Baum, R. P.; Herrmann, K.; Strosberg, J.; Caplin, M.; Öberg, K.; Modlin, I. M.
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • The role and contribution of treatment and imaging modalities in global cervical cancer management: Survival estimates from a simulation-based analysis
    Journal Article

    Ward, Z. J.; Grover, S.; Scott, A. M.; Woo, S.; Salama, D. H.; Jones, E. C.; El-Diasty, T.; Pieters, B. R.; Trimble, E. L.; Vargas, H. A.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: A simulation-based analysis
    Journal Article

    Ward, Z. J.; Scott, A. M.; Hricak, H.; Abdel-Wahab, M.; Paez, D.; Lette, M. M.; Vargas, H. A.; Kingham, T. P.; Atun, R.
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Consensus on molecular imaging and theranostics in prostate cancer
    Journal Article

    Fanti, S.; Minozzi, S.; Antoch, G.; Banks, I.; Briganti, A.; Carrio, I.; Chiti, A.; Clarke, N.; Eiber, M.; De Bono, J.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Convection-enhanced delivery for diffuse intrinsic pontine glioma: A single-centre, dose-escalation, phase 1 trial
    Journal Article

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zhou, Z.; Haque, S.; Zanzonico, P.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Donzelli, M.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • PET-adapted salvage therapy for Hodgkin's lymphoma - Authors' reply
    Journal Article

    Schöder, H.; Moskowitz, C. H.; Moskowitz, A. J.
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save

    • Lancet Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 The Lancet Publishing Group
    Lancet Oncology 1470-2045 Elsevier B.V.
    Lancet Oncology 14702045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Inc.
    Lancet Oncology 14702045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 0094-0143 Unknown
    Lancet Oncology 0732-183X Unknown
    Lancet Oncology 1089-9472 Unknown
    Lancet Oncology 0938-7994 Unknown
    Lancet Oncology 2314-6133 Unknown
    Lancet Oncology 2152-2650 Unknown
    Lancet Oncology 1471-2407 Unknown
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Unknown
    Lancet Oncology 1470-2045 The Lancet Publishing Group
    Lancet Oncology 14702045 Elsevier Inc.
    Lancet Oncology 14702045 Unknown
    The Lancet Oncology 1470-2045 Elsevier Science, Inc.
    The Lancet Oncology 14745488 Elsevier Inc.
    The Lancet Oncology 14745488 Elsevier Inc.
    The Lancet Oncology 14745488 Unknown
    The Lancet Oncology 1474-5488 Elsevier Inc.
    The Lancet Oncology 14702045 Elsevier Inc.
    The Lancet Oncology 14702045 Unknown
    The Lancet Oncology 1470-2045 Elsevier Inc.
    The Lancet. Oncology 1474-5488 Unknown
    The Lancet. Oncology 14745488 Unknown